Xvivo Perfusion AB (publ) (STO: XVIVO)
Sweden
· Delayed Price · Currency is SEK 484.50
-4.50 (-0.92%)
Dec 3, 2024, 11:59 AM CET
Xvivo Perfusion AB Market Cap
Xvivo Perfusion AB has a market cap or net worth of 15.04 billion as of December 3, 2024. Its market cap has increased by 85.80% in one year.
Market Cap
15.04B
Enterprise Value
14.62B
Revenue
750.59M
Ranking
n/a
PE Ratio
72.96
Stock Price
484.50
Market Cap Chart
Since October 8, 2012, Xvivo Perfusion AB's market cap has increased from 371.69M to 15.04B, an increase of 3,946.62%. That is a compound annual growth rate of 35.56%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca PLC | 2,281.98B |
| Swedish Orphan Biovitrum AB (publ) | 103.85B |
| Sectra AB (publ) | 54.85B |
| Getinge AB (publ) | 46.43B |
| Camurus AB (publ) | 33.52B |
| Vitrolife AB (publ) | 30.44B |
| Medicover AB (publ) | 26.39B |
| Elekta AB (publ) | 24.85B |